Theophylline Extended Release (NCS HealthCare of KY, Inc dba Vangard Labs)


Welcome to the PulseAid listing for the Theophylline Extended Release drug offered from NCS HealthCare of KY, Inc dba Vangard Labs. This Methylxanthine [EPC],Xanthines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: NCS HealthCare of KY, Inc dba Vangard Labs
NON-PROPRIETARY NAME: Theophylline, anhydrous
SUBSTANCE NAME: THEOPHYLLINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Methylxanthine [EPC],Xanthines [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1990-04-30
END MARKETING DATE: 0000-00-00


Theophylline Extended Release HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTheophylline Extended Release from NCS HealthCare of KY, Inc dba Vangard Labs
LABELER NAME: NCS HealthCare of KY, Inc dba Vangard Labs
DEA SCHEDULE:
ACTIVE STRENGTH: 300(mg/1)
START MARKETING DATE: 1990-04-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0615-1590_9864e22b-201f-455d-9361-786fad14bb2f
PRODUCT NDC: 0615-1590
APPLICATION NUMBER: ANDA089763

Other THEOPHYLLINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
NCS HealthCare of KY, Inc dba Vangard LabsTheophylline Extended Release
Pharmaceutical Associates, Inc.THEOPHYLLINE